ENA Respiratory is a clinical-stage pharmaceutical company developing INNA-051, an intranasal innate immune modulator for the prevention of complications resulting from respiratory viral infections in at-risk populations, including older adults, those with co-morbidities (COPD, asthma, diabetes, and cardiovascular disease) and individuals with occupational risk. The ENA team has a long history of successful drug development in respiratory diseases and seeks to leverage this expertise to meet the considerable unmet need that still exists for these vulnerable populations.
ENA Respiratory has partnered with the COPD Foundation to enable and optimize patient-centered clinical development of INNA-051 in COPD. In 2022, it joined BLUE KNIGHT™, a joint initiative between Johnson & Johnson Innovation and BARDA designed to accelerate development of potential solutions for future pandemics. In 2023, the company was awarded a $8.18 million contract from the U.S. Department of Defense to support the continued development of INNA-051.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 31 Queen Street, Melbourne,victoria 3000,australia
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- innavac.com
- Keywords
- personnel..
- HQ
- Melbourne, Victoria
Ena Respiratory Questions
Ena Respiratory's website is innavac.com
Ena Respiratory's LinkedIn profile is https://au.linkedin.com/company/enarespiratory-pty-ltd
Ena Respiratory has
9 employees.
View email and phone details for 9
employees at Ena Respiratory.
Ena Respiratory's industry is
Pharmaceutical Manufacturing
Ena Respiratory's top competitors are
Currus Biologics Pty Ltd,
Mesoblast Limited,
Kinoxis Therapeutics Pty Ltd,
Certa Therapeutics,
Cynata Therapeutics,
Nutromics,
Telix Pharmaceuticals Limited,
Propanc Biopharma, Inc. (Otcqb:ppcb),
Denteric Pty Ltd,
Aravax.
Ena Respiratory's categories are Pharmaceutical Manufacturing
Ena Respiratory's founding year is 2020
